i2o Therapeutics: Colorcon Ventures Invests in i20 Therapeutics
Will work together to accelerate i2O's research and development efforts.
Read full article »
i2o is a Massachusetts-based biotechnology company that researches and develops oral peptide and protein therapies for the treatment of cardiometabolic diseases.
Read more